Facebook
Twitter
LinkedIn
Forward
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
|
In the contemporary landscape of healthcare, addressing the multifaceted challenges of obesity demands a holistic approach that transcends traditional medical paradigms.
|
Stress, anxiety, and depression have an outsized role on the appetite regulatory process in the body via complex hormonal pathways.
|
We are amidst a paradigm shift in obesity treatment, spurred by the introduction of newer, highly effective anti-obesity medications.
|
Embark on a comprehensive exploration of patient engagement across the weight management journey.
|
What anti-obesity medications are in development?
|
Rather than weight/BMI, body composition is a better way for individualized assessment of metabolic health in a patient.
|
This talk will focus on minimally-invasive weight loss procedures known as the endoscopic bariatric therapies (“endobariatrics”).
|
This session will discuss strategies to increase access to obesity care while mitigating provider burnout.
|
Obesity medicine clinicians routinely care for patients with diabetes and treatment often results in significant changes in blood glucose and is associated with a high risk for hypoglycemia.
|